Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: HOG GU12-160 Principal Investigator: Picus, Joel
Title: A Randomized Phase 2 Study Comparing Docetaxel Alone to Docetaxel in Combination with OGX-427 in Patients with Relapsed or Refractory Metastatic Urothelial Carcinoma after Receiving a Platinum-containing Regimen
Description: The purpose of this study is to evaluate whether the combination of OGX-427 plus docetaxel will prolong the survival time of compared to docetaxel alone in patients with urothelial cancer whom are no longer responding to platinum-based chemotherapy treatment....MORE
___________________________________________________________________________________________________
 Number: RTOG 0926 Principal Investigator: Gay, Hiram
Title: A Phase II Protocol for Patients with Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging
Description: The purpose of this study is to find out the effects of transurethal surgery followed by radiation therapy plus chemotherapy....MORE
___________________________________________________________________________________________________
 Number: CTSU S1011 Principal Investigator: Grubb, III, Robert
Title: A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed At Time of Radial Cystectomy For Muscle Invasive Urothelial Cancer.
Description: The purpose of this study is to compare the effects, good and/or bad, of performing a standard lymph node removal versus an extended lymph node removal for patients with muscle invasive urothelial cancer....MORE
___________________________________________________________________________________________________
 Number: CALGB 90601 Principal Investigator: Picus, Joel
Title: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, And Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma
Description: The purpose of this study is to compare the effects, good and/or bad, of the combination of the chemotherapy drugs gemcitabine and cisplatin with the combination of gemcitabine, cisplatin, and the experimental drug bevacizumab on transitional cell cancer to find out which is better....MORE
___________________________________________________________________________________________________
 Number: 201306061 Principal Investigator: Picus, Joel
Title: A Phase Ib/II Trial of ALT-801 in Combination with Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Description: The purpose of this research study is to find out what are the side effects of the study drugs, ALT-801, plus gemcitabine with or without cisplatin, in patients with bladder cancer....MORE
___________________________________________________________________________________________________
 Number: 201306057 Principal Investigator: Picus, Joel
Title: A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects with Metastatic Urothelial Cancer
Description: The main purpose is to determine a safe dose of an invesigational drug, AGS15E, by testing the drug at different dose levels. The study will find out what effects, good and/or bad, it has on patients and their cancer....MORE
___________________________________________________________________________________________________
 Number: 201108400 Principal Investigator: Grubb, III, Robert
Title: Analysis of Urine and Tissue Proteomics in Bladder Cancer
___________________________________________________________________________________________________
 Number: 201107136 Principal Investigator: Strope, Seth
Title: Retrospective and Prospective Evaluation of Outcomes after Radical Cystectomy for Bladder Cancer
___________________________________________________________________________________________________
 Number: 201108327 Principal Investigator: Wang-Gillam, Andrea
Title: Phase I Study of Erlotinib and Temsirolimus in Resistant Solid Malignancies
Description: The purpose of this study is to determine the maximum tolerated dose and side effects of the combination of two drugs, temsirolimus and erlotinib, used to treat solid tumor cancers. Temsirolimus is approved by the Food and Drug Administration (FDA) for treatment of renal cancer and is considered inv...MORE
___________________________________________________________________________________________________
 Number: 201107068 Principal Investigator: Lockhart, A. Craig
Title: Phase I Safety and Pharmacokinetic Study of XRP6258 (Cabazitaxel) In Advanced Solid Tumor Patients with Varying Degrees of Hepatic Impairment
Description: The purpose of this study is to determine if Cabazitaxel is a safe treatment for patients with advanced cancers of different types who also have different levels of liver dysfunction. The highest safe dose of cabazitaxel (the maximum tolerated dose, or MTD) that can be given to patients with your le...MORE
___________________________________________________________________________________________________